KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Current Assets (2016 - 2023)

Historic Current Assets for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2023 value amounting to $7.5 million.

  • Palvella Therapeutics' Current Assets fell 8972.0% to $7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.5 million, marking a year-over-year decrease of 8972.0%. This contributed to the annual value of $7.5 million for FY2023, which is 8972.0% down from last year.
  • As of Q4 2023, Palvella Therapeutics' Current Assets stood at $7.5 million, which was down 8972.0% from $59.1 million recorded in Q3 2023.
  • In the past 5 years, Palvella Therapeutics' Current Assets ranged from a high of $137.6 million in Q3 2021 and a low of $7.5 million during Q4 2023
  • Moreover, its 5-year median value for Current Assets was $91.5 million (2020), whereas its average is $91.6 million.
  • As far as peak fluctuations go, Palvella Therapeutics' Current Assets skyrocketed by 6854.64% in 2021, and later tumbled by 8972.0% in 2023.
  • Over the past 5 years, Palvella Therapeutics' Current Assets (Quarter) stood at $115.0 million in 2019, then crashed by 34.16% to $75.7 million in 2020, then surged by 68.55% to $127.6 million in 2021, then tumbled by 42.47% to $73.4 million in 2022, then plummeted by 89.72% to $7.5 million in 2023.
  • Its Current Assets stands at $7.5 million for Q4 2023, versus $59.1 million for Q3 2023 and $66.5 million for Q2 2023.